## Abstract ## Objective Cognitive impairment is an important determinant for functional impairment in Alzheimer's disease. The role of nonβcognitive symptom is uncertain. The objective of this study was to investigate the role of nonβcognitive symptoms as predictive factors for functional outcome
Non-cognitive psychiatric symptoms in vascular and Alzheimer brain disease
β Scribed by Dr. D. Peter Birkett; Julita Agdeppa
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 579 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0885-6230
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Psychiatric symptoms, other than dementia, are compared in two groups of mental hospital patients who came to autopsy and had complete brain examination. One group had Alzheimer brain changes with no cerebral infarction. The other group had cerebral infarction with no Alzheimer brain changes. Onset with a nonβdementing paranoid illness after the age of 50 was commoner in the Alzheimer group. There was no predominance of affective symptoms in either group. Suddenness of onset of psychosis distinguished the infarct cases, even in cases where there was no neurologically evident stroke, and when there were long time intervals between onset and death. Those destined to suffer Alzheimer brain changes had a less sudden onset, fewer discharges and rehospitalizations and more frequent transition to dementia.Β§
π SIMILAR VOLUMES
## Abstract ## Objective The possibility of brain volume reserve effects was examined in a sample of geriatric outpatients with mild cognitive impairment (MCI), Alzheimer's disease (AD) and vascular dementia (VaD). The total intracranial volume (ICV) served as an estimate of the maximum attained b
## Objective: This cross-sectional study examined the relationship of behavioral and psychological symptoms to cognitive and functional impairment in alzheimer's disease (ad). ## Design: One hundred and fourteen patients were evaluated consecutively at a university-affiliated outpatient memory di
## Abstract ## Background Little is known about the rate of progression or associations of cognitive impairment in dementia with Lewy bodies (DLB), or the associations of accelerated decline. ## Method Dementia patients from a case register were evaluated at baseline and 1 year followβup using t
This review was conducted in order to determine the efficacy of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease, and also to determine whether galantamine was a superior pharmacological intervention. Meta-analytic methods were used to analyse the data from eig